GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » Short Interest

Zentek (TSXV:ZEN) Short Interest


View and export this data going back to 2010. Start your Free Trial

What is Zentek Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Zentek's Short Interest

For the Medical Instruments & Supplies subindustry, Zentek's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zentek's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zentek's Short Interest distribution charts can be found below:

* The bar in red indicates where Zentek's Short Interest falls into.


;
;

Zentek Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » Short Interest
Comparable Companies
TSXV:OTC XCNQ:DTR ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST ALGN HOLX NZSE:FPH SOLV ATR
Traded in Other Exchanges
ZTEK:USA ZAY:Germany
Address
24 Corporate Court, Guelph, ON, CAN, N1G 5G5
Website
https://www.zentek.com
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Executives
Colin Stuart Van Der Kuur Senior Officer
Francis Jacques Dubé Director
Ilse Treurnicht Director
John Snisarenko Director
Brian Gerald Bosse Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Gregory Fenton Director
Eric Wallman Director